We describe a technique for HLA-Cw genotyping by digestion of PCR-amplified genes with restriction endonucleases. Locus-specific primers selectively amplified HLA-Cw sequences from exon 2 in a single PCR that avoided coamplification of other classical and nonclassical class I genes. Amplified DNAs were digested with selected enzymes. Sixty-three homozygous cell lines from International Histocompatibility Workshop X and 113 unrelated individual cells were genotyped for HLA-Cw and compared with serology. The present protocol can distinguish 23 alleles corresponding to the known HLA-Cw sequences. Genotyping of serologically undetectable alleles (HLA-Cw Blank) and of heterozygous cells was made possible by using this method. Six additional HLA-Cw alleles were identified by unusual restriction patterns and confirmed by sequencing; this observation suggests the presence of another family of allele-sharing clusters in the HLA-B locus. This PCR-restriction endonuclease method provides a simple and convenient approach for HLA-Cw DNA typing, allowing the definition of serologically undetectable alleles, and will contribute to the evaluation of the biological role of the HLA-C locus.
These molecules present processed antigens to cytotoxic T lymphocytes and play a role as restriction elements in immune recognition. These HLA molecules are also of pivotal importance in allogenic graft rejection. Inadequate matching of HLA antigens of recipient and donor is the main immunological barrier to successful organ transplantation. The outcome of bone-marrow transplantation between related and unrelated individuals depends on the degree of HLA matching in the donor/recipient pair. A single amino acid difference in HLA class I has been demonstrated to cause graft rejection in vivo (2) .
Historically, the definition of HLA allotypes has relied on the pattern of reactivity of individual cells with panels of alloantisera raised in multiparous women, recipients of multiple blood transfusions, or patients after allograft rejection. The advent of newer technologies such as monoclonal antibodies and the isolation of alloreactive cytotoxic T cell clones has permitted a finer dissection of this highly polymorphic system.
Molecules of the HLA-C locus differ from those of HLA-A and -B loci in several respects. The former are associated more weakly with (32 microglobin (3) . The cell-surface expression of HLA-C locus molecules is lower than that of the HLA-A or HLA-B locus molecules (4) . Nevertheless, HLA-C appears able to elicit a cytotoxic response. It has also been reported that some natural killer (NK) cells can specifically recognize and lyse normal allogenic cells. The alloantigen NK-1 on target cells is controlled by HLA-C or by a closely linked gene (5) (6) (7) (8) .
In addition, in renal transplantation it has been documented (9) that one HLA-Cw incompatibility accompanied by an HLA-B22 mismatch leads to rejection.
At the present time, 25 Cw alleles have been defined based on published sequences (10) . Among these, only 8 are identifiable by serology, whereas 18 specificities for HLA-A locus and 28 for HLA-B locus are readily recognized by human alloantisera or monoclonal antibodies (11) . Due to their weak immunogenicity and the lack .of specific reagents, >20% of HLA-C alleles are undetected and typed as "blank" in most populations (12) (13) (14) ; this fact has so far prevented critical evaluation of the role of HLA-Cw in transplantation.
Isoelectrofocusing has allowed the identification of 11 HLA-Cw alleles out of 25 and to the distinction of some subtypes (15) . Certain requirements of this technique, such as lack of HLA-Cw-specific antibodies, lengthy manipulation, as well as the use of radioactivity, do not allow a common use.
PCR-restriction fragment length polymorphism (RFLP) is a powerful method for detecting genetic variability. The principle of this method rests on amplification of the polymorphic domains by the PCR technique (16) (17) (18) . The products obtained are digested by restriction endonucleases that are selected so that every allele is characterized by a profile of particular restriction fragments. The main polymorphic sites of HLA-Cw molecules are located in domains al and a2 (exons 2 and 3), which also constitute the interaction site with the bound peptides. Consequently, we selected two pairs of primers in exon 2. This choice allows us to specifically amplify the HLA-C locus; all known HLA-Cw alleles are amplified by the two exon-2 primers.
The aim of this work was to develop a reliable HLA-Cwtyping method based on PCR-RFLP, which would be available to the clinical laboratory for study of the biological role of the HLA-C locus.
MATERIALS AND METHODS B-Cell Lines. Sixty-three lymphoblastoid cell lines from the International Histocompatibility Workshop X (IHW) were used as reference materials for HLA-C specificities in the present study. Almost all of these lines were derived from homozygous individuals who had been tested by serology. Some samples were included for antigen Cw blank (data not shown).
Population. One hundred and thirteen unrelated healthy donors from a local group were included in this study for HLA-Cw typing. Of these, 41 were characterized by serology (data not shown).
Abbreviations: IHW, International Histocompatibility Workshop X; gf, gene frequency.
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Serology. A total of 30 preselected anti-Cw sera, including three sera of IHW, were used to define the eight HLA-Cw alleles (Cwl-Cw8) by the complement-dependent lymphocyte microcytotoxicity test (19 For detecting known HLA-Cw (10) alleles, 11 restriction endonucleases were used. In the present experiments PCR-RFLP typing was completed in a two-step procedure. The first step was generic HLA-C typing with five restriction endonucleases (MspAI, Dde I, Rsa I, Eag I, and Hae II), and subtyping was achieved in the second step through addition of six supplementary restriction endonucleases (Fok I, BsmAI, Sty I, Ksp I, Bsg I, and Taq I) (Fig. 1) .
In the same way, for exon (20) and will require further investigation. Subtyping of HLA-Cw*0501 and Cw*0801, Cw*0802, and Cw*0803. The HLA-Cw5 (12) and HLA-Cw8 group has four officially recognized alleles: Cw*0501, Cw*0801, Cw*0802, and Cw*0803. Fourteen HLA-Cw5 and/or -Cw8 types from IHW X and 37 HLA-Cw5 and/or -Cw8 types from the unrelated donors were studied. We tried to discriminate among these four alleles by using two restriction enzymes, Dde I and Fsp I, with the PCR product of exon 3 and using Aci I in the second exon. In this study the patterns observed with control cell lines defined as Cw5 or Cw8 are the same. Direct sequencing of exons 2 and 3 has allowed the proof that Cw*0501 and Cw*0802 sequences are identical at nt 233 in exon 3 and in the first 222 bp of exon 2. The only difference between these two alleles in exons 2 and 3 is in nt 229 and 239. Distinction between genotypes Cw*08 and Cw*0501 required an additional allele-specific probe (P22/PR22) (see Materials and Methods). In the present experiments Cw*0801 (25, 26) and Cw*0803 (27) alleles were absent. These rare alleles are not regularly present in the population at large. In this study amplification of exon 3 is not useful routinely and can be used for extreme precision in typing.
Subtyping of HLA-Cw*0701/Cw*0702. Ten Cw7 cell lines and 37 samples from the unrelated donors were typed as Cw*0702. The Cw*0702 allele is not serologically detectable (28, 29) . The nucleotide sequence of these two alleles (10) differs only by the G197 --C substitution in the Cw*0702 allele.
With the previously described sequences Additional Alleles Predicted by Unusual Restriction Pattern. Seven cells from unrelated donors with a restriction pattern not compatible with any known HLA-Cw alleles were found in this study. Two of them showed identical restriction patterns. We have given them the local names 7-71, 7-72, 7-73, 7-74, 7-75, and 7-76, respectively. These alleles associated strongly with Cw*07. To confirm these alleles as predicted from PCR-RFLP, DNA sequencing was done.
Results of the sequencing show that nucleotide substitutions are essentially located in three regions of the HLA-Cw molecules: (i) The silent mutations reside mostly in the connecting loops linking the 83-strands. (ii) For the 7-75 and 7-76 alleles, mutation of 2 nt at positions 24 and 69 causes substitution of two amino acids (Asp-9 -> Tyr and Ser-24 -> Ala). The exchange of these amino acids in the B pocket is a polymorphism of HLA-Cw molecules already described. (iii) As described above, residue 66, which interacts with the antigenic peptide at the A pocket, is described as one of the amino acids characteristic of HLA-Cw molecules; only HLA-Cw*0701, -Cw*1501, -Cw*1502, and -Cw*0702 (see Cw*07 subtyping) alleles possess an arginine instead of the lysine. Two other alleles (7-71 and 7-73) out of six have an Ile-66: Ile-66 is shared by most HLA-B alleles. The-possibility of a contamination of PCR products by the HLA-B locus can be discarded because of several facts: (i) the restriction pattern of HLA-B in PCR-RFLP differs widely from that of HLA-Cw; (ii) had there been contamination by the B locus, we should observe the evidence of three allele signals in our sequencing results, which did not occur; (iii) these alleles, finally, share the other amino acids highly characteristic of the HLA-C locus, Tyr-67, Arg-69, and Gly-45. This homology could have occurred because of an ancestral recombination with the HLA-B locus. Four alleles (7-72, 7-74, 7-75, and 7-76) present a Met-66; this substitution is unusual as it had not been described.
Distribution of HLA-Cw in Caucasian populations. Among the 113 Caucasian individuals tested, the HLA-Cw*C1.10 [gene frequency (gf) of 10.2%] was the most frequent allele among HLA-Cw Blank. HLA-Cw*0702 (gf, 18.6%) and HLACw*0401 (gf, 13.7%) and HLA-Cw*0501 (gf, 11.5%) were the most common HLA-Cw alleles in this population.
HLA-Cw*02021/Cw*02022 (gf, 5.75%) was the only HLACw2 subtype. The HLA-Cw6 family was dominated by Cw*0601 (gf, 6.2%). Other detected alleles showed relatively low frequencies in this population, including Cw*01 (4%), Cw*0302 (4.5%), Cw*0602 (1.33%), Cw*1202 (1.33%), Cw*1401 (3.5%), Cw*1502 (4.9%), and Cw0802 (6.2%).
DISCUSSION
The hallmark of class I antigen-presenting molecules is their polymorphism, which crystallography has shown to be concentrated in functional positions of the antigen-recognition site. The HLA-Cw alleles show fewer differences than their HLA-A and -B homologues, and this property is reflected in a greater homogeneity of the antigen-recognition site. Conservation of sequence in the al-helix and in the B pocket is particularly striking. This conservation reveals that the serological polymorphism of HLA-Cw antigens generally reflects the underlying structures of the cells, which vary in 10 basic motifs. Further, some 20% of HLA-Cw alleles cannot be defined by serological HLA typing. Consequently, the role of HLA-C in immunoregulation (5) (6) (7) (8) , transplantation (37) , and disease susceptibility (38) is largely unknown.
To facilitate investigation of the biological role of HLA-C, we have developed a rapid and reproducible PCR-RFLP genotyping method that has been used successfully to characterize HLA-DPB1 (39), HLA-DQB1 (17, 18) , and HLA-DQA1 (16) allelic polymorphism.
In our study the Cw*0301 was never detected. Cw*0301 was the first HLA-C allele sequenced (4) , and it has an unusually high number of specific substitutions. For HLA-A and -B, several of these substitutions have proved to result from artifacts introduced in cloning and/or sequencing. The results from sequencing AP cell lines (29) show that Cw*0302 allele differs from Cw*0301 by 16 nucleotide substitutions in the coding region (10 amino acid substitutions). (29) . HLA-Aw24 and -A32 share a cluster of sequences with five HLA-B locus alleles (44) . The locus-specific sequences in al and a2 show features that distinguish the products of HIA-A, -B, and -C loci. Certain positions that are conserved in the products of one locus exhibit variation in the products of another. On the basis of Wu and Kabat (45) , the parameter of variability positions and distribution varies with locus, although all are found within the antigen-recognition site (46, 47) . Most amino acids concerned by nucleotide modification in these alleles are found on the a2-helix of the molecule and are described as polymorphic residues of class I molecule (47) . The three amino acids-9, 24, and 66-directly contact the antigenic peptide. Amino acid 9 is described as a highly polymorphic residue, whereas the polymorphism of amino acid 24 is only shared by Cw*07 and Cw*06 subtypes. These results show that even though residue 66 is found in many alleles, it is not commonly shared by all locus C alleles. All inherited changes in the major histocompatibility complex originate with mutations in the germ line of single individuals, which may then be propagated and increased in frequency within the population. The frequency with which new alleles are formed is low, and so no example of an individual expressing an HLA-A, -B, and -C antigen not shared with either parent has been documented. Here, we have presented an extensive analysis of the polymorphism of HLA-Cw alleles by PCR-RFLP technique in the Caucasian population. This protocol is a high-performance technique for reliable tissue typing that allows unequivocal definition of all possible cells, homozygous and heterozygous. The method can be substituted for serological typing methods in HLA matching in transplantation and thus be used to study the weight of the C locus, particularly in bone-marrow transplantation, HLA-disease associations, paternity testing, and functional analysis of HLA antigens in the immunological process.
